AN2 Therapeutics (ANTX) Stock Price Today, Chart, Quote and News | baraka

A

AN2 Therapeutics (ANTX)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About AN2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more

Open
USD2.30
High
USD2.37
Low
USD2.20
52 Week High
USD22.22
Monthly Return
-25.60%
Revenue
--

Daily Vol.
121.38k
Avg. Daily Vol.
315.28k
Market Cap.
74M
52 Week Low
2.20
Annual Return
-71.60%

Stock News

Many Canadians are delaying filing their taxes out of fear of owing money, survey says

Many Canadians are delaying filing their taxes out of fear of owing money, survey says

Yahoo

AI Boom’s Secret Winners? The Companies Expected to Power It

AI Boom’s Secret Winners? The Companies Expected to Power It

Yahoo

Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo

Should You Investigate Keysight Technologies, Inc. (NYSE:KEYS) At US$149?

Should You Investigate Keysight Technologies, Inc. (NYSE:KEYS) At US$149?

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.